Meetings

Use of antipsychotic medication in care homes

This page gives details of any meetings held which will, or did, discuss the matter, and includes links to the relevant Papers, Agendas and Minutes.

Note: Meeting Agenda can change at short notice. Particularly where future meeting dates are indicated more than a week in advance. Please check before planning to attend a Committee Meeting that the item you are interested in has not been moved.

 

 

Meeting: 19/09/2019 - Health, Social Care and Sport Committee - Fifth Senedd (Item 6)

6 Letter from Minister for Health and Social Services regarding antipsychotic medication in care homes

Supporting documents:

Minutes:

6.5  The Committee noted the letter.

Meeting: 13/03/2019 - Health, Social Care and Sport Committee - Fifth Senedd (Item 2)

2 Letter from the Minister for Health and Social Services regarding use of antipsychotic medication in care homes in Wales

Supporting documents:

Minutes:

1.1 The Committee noted the letter.

Meeting: 11/07/2018 - Plenary - Fifth Senedd (Item 7)

Debate on the Health, Social Care and Sport Committee report: Use of antipsychotic medication in care homes

NDM6765 Dai Lloyd (South Wales West)

To propose that the National Assembly for Wales:

Notes the report of the Health, Social Care and Sport Committee on use of antipsychotic medication in care homes, which was laid in the Table Office on 17 May 2018.

Note: The response of the Cabinet Secretary for Health and Social Services to the report was laid in the Table Office on 4 July 2018.

Supporting Document
Letter from the Welsh Government to the Chair of the Health, Social Care and Sport Committee on the use of antipsychotic medication in care homes

 

 

Minutes:

The item started at 16.20

NDM6765 Dai Lloyd (South Wales West)

To propose that the National Assembly for Wales:

Notes the report of the Health, Social Care and Sport Committee on use of antipsychotic medication in care homes, which was laid in the Table Office on 17 May 2018.

Note: The response of the Cabinet Secretary for Health and Social Services to the report was laid in the Table Office on 4 July 2018.

The motion was agreed in accordance with Standing Order 12.36.

Meeting: 03/05/2018 - Health, Social Care and Sport Committee - Fifth Senedd (Item 5)

5 Use of antipsychotic medication in care homes: Consideration of draft report

Paper 4

Supporting documents:

Minutes:

5.1 The Committee considered the draft report.

Meeting: 19/04/2018 - Health, Social Care and Sport Committee - Fifth Senedd (Item 9)

9 Use of antipsychotic medication in care homes: Consideration of draft report

Paper 12

Supporting documents:

Minutes:

9.1 The Committee considered the draft report and will consider further at a future meeting.

Meeting: 31/01/2018 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of antipsychotic medication in care homes - procedure for non-compliance notices by Care Inspectorate Wales

Supporting documents:

Minutes:

3.2a The Committee noted the procedure for non-compliance notices by Care Inspectorate Wales.

Meeting: 31/01/2018 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of antipsychotic medication in care homes - additional information from the Royal Pharmaceutical Society Wales

Supporting documents:

Minutes:

3.1a The Committee noted the additional information from the Royal Pharmaceutical Society Wales.

Meeting: 17/01/2018 - Health, Social Care and Sport Committee - Fifth Senedd (Item 5)

Use of antipsychotic medication in care homes - consideration of evidence and key issues

Minutes:

5.1 The Committee considered the evidence received during item 2 of the meeting.

5.2 The Committee discussed the key issues that have arisen during its inquiry into the use of antipsychotic medication in care homes ahead of the preparation of its draft report.

Meeting: 15/11/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of antipsychotic medication in care homes - Additional information from Hywel Dda University Health Board and Aneurin Bevan University Health Board

Supporting documents:

Minutes:

3.2a The Committee noted the additional information from Hywel Dda University Health Board and Aneurin Bevan University Health Board in relation to the inquiry into the use of antipsychotic medication in care homes.

Meeting: 15/11/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of antipsychotic medication in care homes - Additional information from the Royal College of Speech and Language Therapists and the Royal College of Occupational Therapists

Supporting documents:

Minutes:

3.3a The Committee noted the additional information from the Royal College of Speech and Language Therapists and the Royal College of Occupational Therapists in relation to the inquiry into the use of antipsychotic medication in care homes.

Meeting: 15/11/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of antipsychotic medication in care homes - Additional information from the Care and Social Services Inspectorate Wales

Supporting documents:

Minutes:

3.1a The Committee noted the additional information from the Care and Social Services Inspectorate Wales in relation to the inquiry into the use of antipsychotic medication in care homes.

Meeting: 25/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 4)

Use of antipsychotic medication in care homes - consideration of evidence

Minutes:

4.1 The Committee considered the evidence given during item 2 of the meeting.

Meeting: 25/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 2)

2 Use of antipsychotic medication in care homes - evidence session 14 - Social Care Wales

Gerry Evans, Director of Regulation and Intelligence

Supporting documents:

Minutes:

2.1 The Committee received evidence from Gerry Evans, Social Care Wales.

Meeting: 19/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 11)

Use of anti-psychotic medication in care homes - consideration of evidence

Minutes:

11.1 The Committee considered the evidence given during items 2, 3, 6, 7 and 8 of the meeting.

Meeting: 19/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 2)

2 Use of anti-psychotic medication in care homes - evidence session 9 - Royal College of Occupational Therapists & Royal College of Speech and Language Therapists

Karin Orman, Royal College of Occupational Therapists  

Dr Alison Stroud, Royal College of Speech and Language Therapists

Beth Bowen, Royal College of Speech and Language Therapists

 

Supporting documents:

Minutes:

2.1 The Committee received evidence from representatives of the Royal College of Occupational Therapists and Royal College of Speech and Language Therapists.

Meeting: 19/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 6)

6 Use of anti-psychotic medication in care homes - evidence session 11 - Care and Social Services Inspectorate Wales

David Francis, Assistant Chief Inspector, Care and Social Services Inspectorate Wales

Supporting documents:

Minutes:

6.1 The Committee received evidence from representatives of the Care and Social Services Inspectorate Wales.

6.2 David Francis agreed to provide the Committee with a breakdown of the number care homes in Wales which had been closed by CSSIW for poor service provision.

Meeting: 19/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of anti-psychotic medication in care homes - evidence session 10 - Care Forum Wales

Melanie Minty, Care Forum Wales

Steven Ford, Care Forum Wales

Supporting documents:

Minutes:

3.1 The Committee received evidence from representatives of Care Forum Wales.

Meeting: 19/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 7)

7 Use of anti-psychotic medication in care homes - evidence session 12 - Cwm Taf University Health Board and Cardiff and Vale University Health Board

Mr John Palmer, Director of Primary, Community and Mental Health, Cwm Taf UHB

Mrs Kim Williams, Consultant Psychologist Older Persons Mental Health, Cwm Taf UHB

Victoria Gimson, Specialist Mental Health Pharmacist, Cardiff and Vale UHB

Candace Rowlands, Cardiff and Vale UHB

Supporting documents:

Minutes:

7.1 The Committee received evidence from representatives of Cwm Taf University Health Board and Cardiff and Vale University Health Board.

Meeting: 19/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 8)

Use of anti-psychotic medication in care homes - evidence session 13 - Aneurin Bevan University Health Board and Hywel Dda University Health Board

Claire Aston, Divisional Nurse/Head of Complex Care, Aneurin Bevan UHB

Dr Chineze Ivenso, Old Age Consultant Psychiatrist (Newport Community Mental Health Team), Aneurin Bevan UHB

Sarah Isaac, Senior Pharmacist Manager – Primary Care, Hywel Dda UHB

Sue Stephens, Prescribing Advisor, Hywel Dda UHB

Minutes:

8.1 The Committee received evidence from representatives of Aneurin Bevan University Health Board and Hywel Dda University Health Board.

8.2 Dr Chineze Ivenso agreed to provide the Committee with the findings, so far, of the 2017 audits on the use of antipsychotic medication with patients who have dementia living in care home settings in the Newport borough.

8.3 Both Health Boards agreed to write to the Committee setting out what data on antipsychotic prescribing they believed should be collected nationally to enable health boards to benchmark against other and against NICE standards.

Meeting: 19/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 9)

9 Use of antipsychotic medication in care homes - additional information from Community Pharmacy Wales

Supporting documents:

Minutes:

9.1a The Committee noted the additional information from Community Pharmacy Wales in relation to the inquiry into the use of antipsychotic medication in care homes.

Meeting: 11/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 4)

4 Inquiry into the use of antipsychotic medication in care homes – additional information from the Royal College of Psychiatrists

Supporting documents:

Minutes:

4.3a The Committee noted the additional information from the Royal College of Psychiatrists in relation to the inquiry into the use of antipsychotic medication in care homes.

Meeting: 05/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 9)

Use of antipsychotic medication in care homes - consideration of evidence

Minutes:

9.1 The Committee considered the evidence given during items 2, 3, 4, 5 and 6 of the meeting.

Meeting: 05/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 5)

5 Use of antipsychotic medication in care homes - evidence session 7 - Royal Pharmaceutical Society and Community Pharmacy Wales

Mair Davies, Director, Royal Pharmaceutical Society Wales

Wendy Davies, Mental Health Clinical Board Pharmacist, Royal Pharmaceutical Society Wales

Steve Simmonds, Community Pharmacy Wales

Sam Fisher, Community Pharmacy Wales

Supporting documents:

Minutes:

5.1 The Committee received evidence from representatives of the Royal Pharmaceutical Society and Community Pharmacy Wales.

5.2 The Royal Pharmaceutical Society and Community Pharmacy Wales agreed to provide additional evidence.

Meeting: 05/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 4)

4 Use of antipsychotic medication in care homes - evidence session 6 - Royal College of Nursing

Alison Davies, Associate Director Professional Practice, Royal College of Nursing Wales

Helen Bennett, Mental Health Nurse and Mental Health Consultant, Royal College of Nursing Wales

Supporting documents:

Minutes:

4.1 The Committee received evidence from representatives of the Royal College of Nursing.

Meeting: 05/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 2)

2 Use of antipsychotic medication in care homes - evidence session 4 - Public Health Wales NHS Trust

Michaela Morris, Mental Health Service Improvement Manager, Public Health Wales.

Rhiannon Davies

 

Supporting documents:

Minutes:

2.1 The Committee received evidence from representatives of Public Health Wales NHS Trust.

Meeting: 05/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 6)

6 Use of antipsychotic medication in care homes - evidence session 8 - British Psychological Society

Dr Ian James, British Psychological Society

Dr Carolien Lamers, British Psychological Society

Supporting documents:

Minutes:

6.1 The Committee received evidence from representatives of the British Psychological Society.

Meeting: 05/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 7)

7 Inquiry into the use of antipsychotic medication in care homes - note of session on 21 September 2017

Supporting documents:

Minutes:

7.1a The Committee noted the note of the private session on 21 September 2017.

Meeting: 05/10/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of antipsychotic medication in care homes - evidence session 5 - Royal College of Psychiatrists and Royal College of General Practitioners

Dr Victor Aziz, Royal College of Psychiatrists

Dr Jane Fenton-May, Royal College of General Practitioners

Supporting documents:

Minutes:

3.1 The Committee received evidence from representatives of the Royal College of Psychiatrists and the Royal College of General Practitioners.

Meeting: 21/09/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 8)

Use of antipsychotic medication in care homes - evidence session 5 - people affected by the use of antipsychotic medication in care homes

Minutes:

8.1 The Committee heard from a person who has had direct experience of the use of anti-psychotic medication in care homes and hospital settings.

Meeting: 21/09/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 2)

2 Use of antipsychotic medication in care homes - evidence session 1 - Older People's Commissioner for Wales

Sarah Rochira, Older People's Commissioner for Wales

Supporting documents:

Minutes:

2.1 The Committee received evidence from the Older People’s Commissioner for Wales.

Meeting: 21/09/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of antipsychotic medication in care homes - evidence session 2 - Alzheimer's Society Cymru

Sue Phelps, Country Director, Alzheimer's Society Cymru

Supporting documents:

Minutes:

3.1 The Committee received evidence from Sue Phelps of Alzheimer’s Society Cymru.

Meeting: 21/09/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 5)

Use of antipsychotic medication in care homes - evidence session 4 - people affected by the use of antipsychotic medication in care homes

Suzanne Tarrant

Minutes:

5.1 The Committee received evidence from Suzanne Tarrant.

Meeting: 21/09/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 9)

Use of anti-psychotic medication in care homes - consideration of evidence

Minutes:

9.1 The Committee considered the evidence given during items 2 3, 4, 5 and 8 of the meeting.

Meeting: 21/09/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 4)

4 Use of antipsychotic medication in care homes - evidence session 3 - Professor Sue Jordan

Professor Sue Jordan

Tim Banner, Consultant Pharmacist

Supporting documents:

Minutes:

4.1 The Committee received evidence from Professor Sue Jordan and Tim Banner.

Meeting: 17/05/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 7)

7 Use of anti-psychotic medication in care homes - inquiry refresh

Supporting documents:

Minutes:

7.1 The Committee had further discussions about its inquiry into the use of anti-psychotic medication in care homes and agreed to issue invites to stakeholders to attend evidence gathering sessions in the autumn term.

Meeting: 11/05/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 10)

10 Use of anti-psychotic medication in care homes - inquiry refresh

Supporting documents:

Minutes:

10.1 The Committee agreed to defer consideration of this item until the following week’s meeting.

Meeting: 01/03/2017 - Health, Social Care and Sport Committee - Fifth Senedd (Item 3)

3 Use of anti-psychotic medication - consideration of scope and approach to the inquiry

Supporting documents:

Minutes:

3.1 The Committee considered and agreed the scope and approach to its inquiry with into the use of anti-psychotics, and agreed to issue a public consultation.  

 

Topics

Helpful Links

Related